Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A glucose-dependent spatial patterning of exocytosis in human β cells is disrupted in type 2 diabetes
Jianyang Fu, John Maringa Githaka, Xiaoqing Dai, Gregory Plummer, Kunimasa Suzuki, Aliya F. Spigelman, Austin Bautista, Ryekjang Kim, Dafna Greitzer-Antes, Jocelyn E. Manning Fox, Herbert Y. Gaisano, Patrick E. MacDonald
Jianyang Fu, John Maringa Githaka, Xiaoqing Dai, Gregory Plummer, Kunimasa Suzuki, Aliya F. Spigelman, Austin Bautista, Ryekjang Kim, Dafna Greitzer-Antes, Jocelyn E. Manning Fox, Herbert Y. Gaisano, Patrick E. MacDonald
View: Text | PDF
Research Article Cell biology Endocrinology

A glucose-dependent spatial patterning of exocytosis in human β cells is disrupted in type 2 diabetes

  • Text
  • PDF
Abstract

Impaired insulin secretion in type 2 diabetes (T2D) is linked to reduced insulin granule docking, disorganization of the exocytotic site, and impaired glucose-dependent facilitation of insulin exocytosis. We show in β cells from 80 human donors that the glucose-dependent amplification of exocytosis is disrupted in T2D. Spatial analyses of granule fusion events, visualized by total internal reflection fluorescence microscopy in 24 of these donors, demonstrated that these events are nonrandom across the surface of β cells from donors with no diabetes. The compartmentalization of events occurs within regions defined by concurrent or recent membrane-resident secretory granules. This organization, and the number of membrane-associated granules, is glucose dependent and notably impaired in T2D β cells. Mechanistically, multichannel Kv2.1 clusters contribute to maintaining the density of membrane-resident granules and the number of fusion “hotspots,” while SUMOylation sites at the channel N- (K145) and C-terminus (K470) determine the relative proportion of fusion events occurring within these regions. Thus, a glucose-dependent compartmentalization of fusion, regulated in part by a structural role for Kv2.1, is disrupted in β cells from donors with T2D.

Authors

Jianyang Fu, John Maringa Githaka, Xiaoqing Dai, Gregory Plummer, Kunimasa Suzuki, Aliya F. Spigelman, Austin Bautista, Ryekjang Kim, Dafna Greitzer-Antes, Jocelyn E. Manning Fox, Herbert Y. Gaisano, Patrick E. MacDonald

×

Figure 7

SUMOylation sites on the Kv2.1 N- and C-termini control β cell exocytosis.

Options: View larger image (or click on image) Download as PowerPoint
SUMOylation sites on the Kv2.1 N- and C-termini control β cell exocytosi...
(A) When expressed in human embryonic kidney 293 (HEK293) cells, mutation of Kv2.1 C-terminal (K470R) or N-terminal (K145R) SUMOylation sites, alone or in combination, has no effect on channel protein level (representative of 3 experiments). (B) When expressed in INS 832/13, cells’ loss of the K145 site has no effect on channel current measured by whole-cell patch-clamp electrophysiology, while currents are increased upon mutation of K470 or of both sites in concert (n = 16, 20, 27, 20, and 28 cells). (C–F) When examined by measurement of cell capacitance responses, SUMO1 suppresses exocytosis in INS 832/13 (C) cells expressing Kv2.1-WT (n = 23, 18 cells), and this effect is reduced in (D) cells expressing Kv2.1-K145R (n = 16, 18 cells) or (E) cells expressing Kv2.1-K470R (n = 27, 29 cells). (F) Mutation of both SUMOylation sites (Kv2.1-K145/470R; n = 24, 14 cells) abolished the inhibitory effect of SUMO1 on exocytosis. Significance was determined by (B) Kruskal-Wallis 1-way ANOVA followed by Mann-Whitney posttest, by (C and E) nonparametric Mann-Whitney test alone, or (D and F) by Student’s t test. *P < 0.05; **P < 0.01; and ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts